falsefalse

Exploring Hepatotoxicity and Treatment Outcomes of Targeting KRAS G12C Mutations in mNSCLC - Episode 3

Clinical Perspectives of KRAS G12C Inhibitors in NSCLC Mutations

,

Shared insight into the consideration of KRAS G12C inhibitors in treating co-mutations in NSCLC.

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    x